The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Galliker Stephen S since year 2005.
The trader's CIK number is 1249422.
At the time of this reporting, Galliker Stephen S is the Director of Rxi Pharmaceuticals Corp .
(stock ticker symbol RXII).
See this page for all insider trading activities at Rxi Pharmaceuticals Corp .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2014-02-03||GALE||Rxi Pharmaceuticals Corp||Sale||300,000||4.18||1,253,099|
|2014-02-03||GALE||Rxi Pharmaceuticals Corp||Option Ex||300,000||1.35||406,200|
|2010-06-18||OSTE||Osteotech Inc||Option Ex||5,000||.00||0|
|2010-03-26||RXII||Rxi Pharmaceuticals Corp||Sale||15,000||5.54||83,100|
|2009-06-19||OSTE||Osteotech Inc||Option Ex||5,000||.00||0|
|2008-06-21||OSTE||Osteotech Inc||Option Ex||5,000||.00||0|
|2007-06-21||OSTE||Osteotech Inc||Option Ex||5,000||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Galliker Stephen S (Director of Rxi Pharmaceuticals Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.